Delivery Order SPE2DB20D2104-SPE2DB24FS21Q

Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4563237224 ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $1,630.67 and an ultimate completion date of January 5, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM. The contract has a ceiling value of $5,708.49 and a completion date of January 4, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,134.76 firm fixed-price contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a type of pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The contract has a firm fixed price of $10,160.34 and a period of performance through August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,641.58, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. The award has a ceiling value of $14,598.68 and an ultimate completion date of August 29, 2024. The contract is a firm fixed-price delivery order, indicating that AmerisourceBergen will provide the specified quantity of inhalers at a predetermined price. This contract does not have a set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,920.85 and an ultimate completion date of October 21, 2024. It is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order and was not set aside for any specific business category....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.80 firm-fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of November 17, 2022 and was awarded on November 16, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a firm fixed price of $2,403.52 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $15,129.35 and runs until July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS21Q
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the purchase of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $4,283.99 and an ultimate completion date of January 25, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 10:31 AM